Peanut Allergy Rates Fall 43% as Infant Feeding Guidance Shifts
New data indicates that introducing peanut products to infants between four and six months old has drastically reduced the risk of developing allergies in children under age three.
By Ethan Cooper ·
Peanut allergy rates in young children have dropped sharply in recent years.
A study released in October 2025 found that the rate of peanut allergies among children under three has fallen by roughly 43 percent over the last decade. This decline coincides with a shift in medical guidance regarding infant nutrition. Researchers indicate that introducing peanut products to infants between the ages of four and six months can substantially lower the risk of developing an allergy. Previous long-held medical advice suggested that parents should avoid peanut products for young children. The new research suggests that this earlier approach may have been counterproductive.
Dr. Rhea Rogers, a board-certified physician, addressed other aspects of health and aging on the program Aging Untold. She noted that many couples struggle with misconceptions about intimacy after a health diagnosis. Rogers stated that one of the largest errors couples make is treating intimacy and sexuality as interchangeable concepts. She explained that they are distinct aspects of a relationship. Sam Cradduck, a gerontologist, advised that the first step for couples is to identify the cause of any changes in their sex life. Cradduck emphasized that competence and consent are the primary factors to consider in these conversations. She added that doctors can often help manage physical issues such as erectile dysfunction.
The program also discussed the participation of older adults in clinical trials. Experts on Aging Untold said that older adults are frequently underrepresented in these studies. However, they noted that clinical trials offer a proactive way for seniors to explore new treatments. Rogers advised that participants should first consider what specific question a trial is designed to answer. She described clinical trials as a way to gain access to future medical advancements. Rogers stated, "You get great access to tomorrow's medicines today, devices, therapies and other things that will not be available to everybody else for years." Aging expert Amy O'Rourke warned that participants must understand they might receive a placebo during the trial period.
Flo Meiler, a 91-year-old woman from Vermont, illustrated the potential for active aging. She began competing in track and field at the age of 60. Meiler now holds two world records and fills her home with medals. She continues to compete in athletic events. Meiler said, "I'm sad that I can't jump like I used to, but I really enjoy it."
